Wave Life Sciences

$9.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+0.54%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell WVE and other stocks, options, and ETFs commission-free!

About WVE

Wave Life Sciences Ltd. Ordinary Shares, also called Wave Life Sciences, is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore. The listed name for WVE is Wave Life Sciences Ltd. Ordinary Shares.

CEO
Paul B. Bolno
Employees
301
Headquarters
Singapore, Central Singapore
Founded
2012
Market Cap
340.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
726.47K
High Today
$9.50
Low Today
$9.22
Open Price
$9.23
Volume
276.59K
52 Week High
$39.98
52 Week Low
$6.61

Collections

WVE Earnings

-$1.65
-$1.10
-$0.55
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like